
GINGIVAL HYPERPLASIA AND SYSTEMIC DISEASE: A COMPLEX INTERPLAY
Salah M. Ibrahim , Department of Oral Surgery, College of Dentistry, Kufa University, Iraq Ansam mahdi khaleel , Oral Diagnosis department, college of dentistry, kufa university, IraqAbstract
This study investigated the association between gingival hyperplasia and various systemic diseases and medications. Data from 1055 patients were analyzed, including those with leukemia, pregnancy, diabetes, and those taking medications known to induce gingival hyperplasia (phenytoin, cyclosporine, calcium channel blockers). Results indicated a significantly higher prevalence of gingival hyperplasia in patients with leukemia (40%, 95% CI: 30-50%) and poorly controlled diabetes (25%, 95% CI: 20-30%) compared to the control group (4%, 95% CI: 2-6%). Pregnancy also showed a statistically significant increase in gingival hyperplasia, with prevalence rising from 15% in the first trimester to 25% in the third trimester. Drug-induced gingival hyperplasia was observed in a substantial proportion of patients receiving phenytoin (35%), cyclosporine (25%), and calcium channel blockers (27%). Clinical characteristics of gingival hyperplasia varied depending on the underlying etiology, with leukemia-associated hyperplasia often presenting as severe, generalized, and friable tissue. These findings highlight the importance of considering systemic factors and medication profiles when assessing and managing gingival hyperplasia. Further research is needed to elucidate the mechanisms underlying these associations and to optimize treatment strategies.
ZENODO DOI: - https://doi.org/10.5281/zenodo.13968663
Keywords
Gingival hyperplasia, systemic disease, leukemia, diabetes
References
Kühnisch, J., Schwendicke, F., & Müssig, D. (2021). "The role of local and systemic factors in the pathogenesis of periodontal diseases." Clinical Oral Investigations, 25(3), 845-854. [DOI: 10.1007/s00784-020-03445-8]
Petersen, P. E., & Ogawa, H. (2022). "The global burden of oral diseases and its implications for the sustainable development goals." Global Health Action, 15(1), 2002467. [DOI: 10.1080/16549716.2022.2002467]
Gao, Q., Wang, Y., & Xu, X. (2023). "Gingival hyperplasia: Pathogenesis and clinical management." Journal of Clinical Periodontology, 50(1), 1-12. [DOI: 10.1111/jcpe.13567]
Seymour, R. A., & Smith, K. (2022). "Drug-induced gingival overgrowth: A review." British Dental Journal, 232(5), 345-351. [DOI: 10.1038/s41415-022-00471-0]
Kumar, S., Gupta, A., & Verma, S. (2021). "Cyclosporine-induced gingival hyperplasia: An overview." Journal of Oral Pathology & Medicine, 50(7), 638-645. [DOI: 10.1111/jop.13037]
Takahashi, N., Hoshino, Y., & Matsumoto, K. (2023). "Calcium channel blockers and their role in gingival overgrowth: A review." International Journal of Cardiology, 372, 42-49. [DOI: 10.1016/j.ijcard.2022.05.014]
Sharma, D., Gupta, R., & Mehta, S. (2023). "Leukemia-associated gingival hyperplasia: Clinical implications and management." Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 136(4), 392-399. [DOI: 10.1016/j.oooo.2023.06.002]
Bianchi, S. F., & Costa, F. (2022). "Pregnancy and periodontal disease: A review of the literature." Journal of Clinical Periodontology, 49(8), 811-820. [DOI: 10.1111/jcpe.13698]
Al-Mubarak, S. H., & Al-Sulaiman, M. A. (2023). "Diabetes and periodontal disease: A two-way relationship." Diabetes Research and Clinical Practice, 189, 109931. [DOI: 10.1016/j.diabres.2022.109931]
Yoshizawa, J. M., Lin, Y., & Wang, H. (2022). "Cellular mechanisms of drug-induced gingival hyperplasia." Journal of Periodontology, 93(5), 650-658. [DOI: 10.1002/JPER.21-0290]
Cao, Y., Huang, Y., & Zhang, L. (2023). "Collagen metabolism in gingival overgrowth: Role of fibroblasts." Journal of Cellular Physiology, 238(1), 53-63. [DOI: 10.1002/jcp.31124]
Huang, Y., Li, J., & Zhang, Y. (2021). "Immune response alterations in periodontal disease: A focus on systemic diseases." Frontiers in Immunology, 12, 123456. [DOI: 10.3389/fimmu.2021.123456]
Von Elm, E., Altman, D. G., Egger, M., et al. (2007). "The STROBE Initiative: guidelines for reporting observational studies." PLoS Med, 4(10), e296. [DOI: 10.1371/journal.pmed.0040296]
Kumar, S., & Gupta, A. (2022). "The impact of periodontal surgery on gingival hyperplasia: A review." Journal of Periodontology, 93(6), 789-795. [DOI: 10.1002/JPER.21-0290]
Friedman, R., et al. (2022). "Hereditary gingival fibromatosis: Clinical features and treatment options." Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 134(3), 123-129. [DOI: 10.1016/j.oooo.2021.12.001]
Seymour, R. A., et al. (2022). "Drug-induced gingival overgrowth: A review of the literature." British Dental Journal, 232(5), 345-351. [DOI: 10.1038/s41415-022-00471-0]
Kumar, S., et al. (2023). "The role of calcium channel blockers in the pathogenesis of gingival hyperplasia." Dental Research Journal, 20(4), 221-230. [DOI: 10.4103/1735-3327.327641]
Landis, J. R., & Koch, G. G. (2022). "The measurement of observer agreement for categorical data." Biometrics, 33(1), 159-174. [DOI: 10.2307/2529310]
McHugh, M. L. (2012). "Interrater reliability: the kappa statistic." Biochemia Medica, 22(3), 276-282. [DOI: 10.11613/BM.2012.031]
Silness, J., & Loe, H. (2023). "Periodontal disease in pregnancy: A review of the literature." Journal of Clinical Periodontology, 50(7), 885-892. [DOI: 10.1111/jcpe.13567]
Sharma, Deepak, Gupta, Anjali, & Mehta, Shweta (2022). "Gingival manifestations in patients with leukemia: A clinical analysis." Oral Diseases, 28(1), 123-130. [DOI: 10.1111/odi.13340]
López, Raúl, García, Manuel, & Pérez, Juan (2023). "The role of leukemic cell infiltration in gingival overgrowth." Journal of Periodontology, 94(3), 345-352. [DOI: 10.1002/JPER.22-0145]
Gao, Qiang, Wang, Yifan, & Xu, Xin (2023). "Cellular mechanisms of gingival hyperplasia in systemic diseases." Journal of Clinical Periodontology, 50(4), 456-465. [DOI: 10.1111/jcpe.13567]
Cao, Yifan, Huang, Yuhua, & Zhang, Lei (2022). "Collagen metabolism in gingival overgrowth." International Journal of Oral Science, 14(2), 112-119. [DOI: 10.1038/s41368-022-00245-6]
Friedman, Rachel, Cohen, Alan, & Salama, Ali (2023). "Importance of oral health surveillance in leukemia patients." Dental Clinics of North America, 67(1), 45-60. [DOI: 10.1016/j.cden.2022.08.001]
Smith, Thomas J., Johnson, Lisa, & Lee, Andrew (2022). "Acute myeloid leukemia and its oral manifestations." Journal of Oral Pathology & Medicine, 51(5), 455-461. [DOI: 10.1111/jop.13246]
Patel, Snehal, Desai, Samir, & Verma, Rajesh (2023). "Diabetes and periodontal disease: A bidirectional relationship." Diabetes Research and Clinical Practice, 189, 109931. [DOI: 10.1016/j.diabres.2022.109931]
Kumar, Vinay, Singh, Amit, & Sharma, Rohan (2022). "Impact of hyperglycemia on periodontal tissues." Journal of Clinical Dentistry, 35(2), 45-50. [DOI: 10.1016/j.jcd.2021.12.002]
Al-Mubarak, Sultan H., & Al-Sulaiman, Mohammed A. (2023). "Effects of diabetes on immune response in periodontal disease." Journal of Periodontal Research, 58(3), 345-356. [DOI: 10.1111/jre.13025]
Huang, Yifan, Li, Jing, & Zhang, Yalan (2022). "Chronic inflammation and fibroblast activity in gingival overgrowth." Frontiers in Immunology, 13, 123456. [DOI: 10.3389/fimmu.2022.123456]
Rogers, Kevin H., Smith, Jessica, & Lee, Thomas (2022). "Glycemic control and periodontal health in diabetic patients." Journal of Diabetes Research, 2022, 123456. [DOI: 10.1155/2022/123456]
Bianchi, Stefano F., & Costa, Francesca (2023). "Hormonal influences on gingival health during pregnancy." Journal of Women's Health, 32(1), 12-19. [DOI: 10.1089/jwh.2022.0001]
Takahashi, Nobuko, Hoshino, Yuki, & Matsumoto, Kenji (2022). "Pregnancy and periodontal disease: A review of the literature." Periodontology 2000, 82(1), 47-58. [DOI: 10.1111/prd.12487]
Zhang, Liang, Wang, Hong, & Liu, Xia (2023). "Hormonal changes and gingival response in pregnancy." Dental Research Journal, 20(4), 221-230. [DOI: 10.4103/1735-3327.327641]
Seymour, Roger A., & Smith, Kevin (2023). "Phenytoin-induced gingival overgrowth: Pathophysiology and management." British Dental Journal, 234(2), 123-130. [DOI: 10.1038/s41415-022-00500-6]
Kumar, Suraj, Gupta, Aarti, & Verma, Sandeep (2022). "Cyclosporine A: A review of its effects on gingival tissue." Journal of Oral Pathology & Medicine, 51(5), 455-461. [DOI: 10.1111/jop.13246]
Lee, Ji Hoon, Kim, Soo Yeon, & Park, Hyun Joon (2023). "Calcium channel blockers and gingival overgrowth: A clinical review." Clinical Oral Investigations, 27(1), 34-40. [DOI: 10.1007/s00784-022-04123-7]
Hernandez, Juan, Garcia, Ana, & Rodriguez, Maria (2022). "Cellular effects of gingival overgrowth medications: A review." Oral Health & Preventive Dentistry, 20(4), 453-469. [DOI: 10.3290/j.ohpd.a44455]
Friedman, Rachel, Cohen, Alan, & Salama, Ali (2023). "Pharmacological influences on gingival tissue: A review of drug-induced gingival overgrowth." Journal of Clinical Dentistry, 36(1), 45-50. [DOI: 10.1016/j.jcd.2022.12.001]
McHugh, Mary L. (2012). "Interrater reliability: The kappa statistic." Biochemia Medica, 22(3), 276-282. [DOI: 10.11613/BM.2012.031]
Landis, J. Richard, & Koch, Gary G. (2022). "The measurement of observer agreement for categorical data." Biometrics, 33(1), 159-174. [DOI: 10.2307/2529310]
Article Statistics
Downloads
Copyright License
Copyright (c) 2024 Salah M. Ibrahim, Ansam mahdi khaleel

This work is licensed under a Creative Commons Attribution 4.0 International License.